Mepenzolate Bromide
Mepenzolate Bromide is a muscarinic receptor antagonist employed in research to investigate gastrointestinal disorders. It is used in in vitro and in vivo studies to explore antispasmodic mechanisms and the role of muscarinic signaling in gut motility and secretion.
Product Specifications
CAS Number
76-90-4
Product Name Alternative
HCAR2, HCA2, hypermotility, gastrointestinal, HM74A, hM3R, hM2R, Mepenzolate, Mepenzolate Bromide, GPR109A, mAChR, muscarinic, Colibantil, COPD, bronchodilatory, Cantil, Cantilaque, PUMA-G
Field of Research
Metabolism Research, Neuroscience, Pharmacology & Drug Discovery
Purity
95.73% (May vary between batches)
Solubility
H2O:10 mg/mL (23.79 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.38 mM) ; DMSO:250 mg/mL (594.76 mM)
Smiles
[Br-].C[N+]1 (C) CCCC (C1) OC (=O) C (O) (c1ccccc1) c1ccccc1
Molecular Formula
C21H26BrNO3
Molecular Weight
420.34
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TMPY-04096-05 100 µg
ST2/IL-1 RL1 Protein, Mouse, Recombinant (His)
Sign In for Pricing
View Details